SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-22-034907
Filing Date
2022-02-11
Accepted
2022-02-10 20:39:30
Documents
2
Group Members
VERSANT VANTAGE II GP, L.P.VERSANT VANTAGE II GP-GP, LLCVERSANT VANTAGE II, L.P.VERSANT VENTURES VI GP, L.P.VERSANT VENTURES VI GP-GP, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d285445dsc13g.htm SC 13G 119719
2 EX-99.1 d285445dex991.htm EX-99.1 9805
  Complete submission text file 0001193125-22-034907.txt   131238
Mailing Address ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104 (415) 801-8100
Versant Venture Capital VI, L.P. (Filed by) CIK: 0001687880 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Subject) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92725 | Film No.: 22616232
SIC: 2836 Biological Products, (No Diagnostic Substances)